On January 18, Sandoz and Biocon announced a new biosimilar partnership, which could extend both manufacturers’ market presence. Although the specific biosimilar targets were not specified, the firms indicated that they will work to develop and commercialize next-generation oncology and immunology biosimilars. Unlike other partnerships that are delineated along the lines of manufacturing and marketing, … Continue reading Sandoz and Biocon Partner on Next-Gen Biosimilars →